Ryan White Clinic? Attend the 340B Ryan White National Conference.

ahfwebUncategorized

Are you worried about an HRSA audit? Do you have questions about how you can spend your 340B funds? Are you a Ryan White grantee? Then you’re in luck. This year, Cempa Community Care is hosting a 340B National Conference specifically for Ryan White Clinics. Join them on Thursday, August 1st, 2019 for reports from national & local Tennessee health … Read More

Drug Companies answer Scrutiny with more Lobbying Dollars

ahfwebUncategorized

May 2, 2019— With its pricing practices under a congressional microscope, the pharmaceutical industry’s top trade group spent nearly $10 million on lobbying expenditures in the first three months of this year. That figure is on top of additional millions spent by some of the individual companies that have received the most attention recently in the drug pricing debate. The … Read More

Let’s Celebrate Maternal Health on Mother’s Day

ahfwebUncategorized

May 10, 2019— For those of us dedicated to safety-net hospitals and the patients they serve, Mother’s Day is about much more than homemade cards and breakfast in bed. It’s also about recognizing that honoring mothers means ensuring access to maternal health, especially for women living in underserved areas. The issue of maternal health is one that is close to … Read More

How special interests get their way in DC: Front groups, former Democratic senators, Democratic public affairs shops doing the dirty work of their supposed “adversaries.”

ahfwebUncategorized

One of the biggest political fights brewing in Washington DC is over Medicare potentially changing to direct negotiations with drugmakers over drug pricing for seniors in the entitlement program. Generally a policy favored on the left, it was also championed by President Trump on the 2016 campaign trail and continues to hold his interest. Conservatives are largely opposed, but in … Read More

340B Key to Trump Administration’s HIV Strategy

ahfwebUncategorized

April 25, 2019— President Trump’s ambitious campaign to end the HIV epidemic in the U.S. will rely heavily on the 340B drug pricing program, according to senior administration officials. A key focus of the effort is to connect people at risk of HIV infection to pre-exposure prophylaxis (PrEP), a treatment that can cost nearly $2,000 a month. In his State … Read More

Don’t Buy Big Pharma Lies

ahfwebUncategorized

In its efforts to discredit the 340B drug pricing program, the pharmaceutical industry has released misleading reports, stating that 340B contributes to high drug prices. As advocates for this program, we know that 340B has lived up to congressional expectations, making a negligible impact on drug prices in the United States.  Big pharmaceutical companies continue to push this platform and have the money and … Read More

Drug Industry Sends its Shills to Senate Hearing on Drug Prices

ahfwebUncategorized

Pharmaceutical CEOs too cowardly to appear before Senate Finance Committee; lackeys instead try to blame the 340B drug discount program, which is only a tiny sliver of the $457 billion U.S. drug market. WASHINGTON (January 29, 2019) US Senate Finance Committee Chairman Chuck Grassley (R-IA) convened an historic hearing on drug prices earlier today and he and the committee ranking … Read More

700 Hospitals Urge Lawmakers To Protect 340B Drug Discount Program

ahfwebUncategorized

More than 700 hospitals and health systems are asking House and Senate leadership to protect the 340B drug discount program in light of recent regulations and legislative proposals the providers say would “undo more than two decades of bipartisan work” on the safety net. “Americans are right to be upset with the high prices being charged for new and existing … Read More

Writing in The New York Times, Economist Ignores Research Showing 340B Is Working

ahfwebUncategorized

Source: 340Binformed.org September 7, 2018—Healthcare economist Austin Frakt recently wrote in The New York Times that the 340B drug discount program includes hospitals “that don’t need the extra help” and don’t use the program to benefit low-income patients. That’s a one-sided view that ignores research showing 340B is working as Congress intended. The research Frakt overlooks includes findings that 340B hospitals care … Read More

Bolstering the 340B Program improves the health care ecosystem in our communities

ahfwebUncategorized

By Rep. Doris Matsui (D-Calif.), Opinion Contributor As a country, we are struggling to address what has become a tragic opioid epidemic gripping the nation. Our community health care providers are on the front lines of this crisis. While hospitals and clinics work tirelessly to both prevent and treat substance use disorder, they are simultaneously fending off constant threats of … Read More